Right Robotic-Assisted Transthoracic Truncal Vagotomy for Marginal Ulcer Disease after Gastric Bypass Surgery

Brungardt, Joseph G.; Tracy, Brett M.; McBride, Katherine; Standiford, Darron; Bailey, B.Marcus

doi:10.1177/000313481808400828

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For patients resistant to marginal ulcer treatment, even with appropriate measures, truncal vagotomy may present itself as a viable stand-alone strategy for healing before considering anastomotic revision. Truncal vagotomy, first described in 1947 for healing a GJA ulcer [87] , can be conducted either laparoscopically [88] or thoracoscopically [89][90][91] . In a study by Bonanno et al [90] , where 20 patients with resistant marginal ulceration underwent either GJA revision or thoracoscopic truncal vagotomy (TTV), results indicated comparable ulcer recurrence rates between GJ revisions (15%) and TTV (14%).…”

Section: Truncal Vagotomymentioning

confidence: 99%

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Baldwin,

Ali,

Altieri

et al. 2024

Metab Target Organ Damage

View full text Add to dashboard Cite

Roux-en-Y gastric bypass (RYGB)-associated marginal ulceration (MU) poses significant challenges for both patients and clinicians. Persistent symptoms such as epigastric pain, nausea, and reduced oral intake complicate the clinical landscape. MU can lead to severe complications, including anastomotic strictures, bleeding, and perforations. The etiology of MU is intricate, likely stemming from a combination of technical and patient-related factors. Technical considerations involve ischemia, tension on the anastomosis causing tissue ischemia, anastomotic technique, gastric pouch size, foreign bodies, and gastrogastric fistulas. Patient factors encompass smoking, nonsteroidal anti-inflammatory drugs (NSAIDs), Helicobacter pylori (H. pylori), and uncontrolled medical comorbidities. Diagnosis primarily relies on upper endoscopy. Initial treatment typically involves proton pump inhibitors (PPI) and sucralfate. Should these measures prove insufficient, the addition of misoprostol and the implementation of endoscopic techniques, such as oversewing or stenting across the ulcer, may be considered to facilitate healing. Ultimately, if medical and endoscopic interventions fail, surgical options become imperative. These include transthoracic truncal vagotomy and revisional procedures such as resection of the ulcer with redo gastrojejunal anastomosis, resection of the ulcer and pouch with esophagojejunal anastomosis, or resection and reversal to normal anatomy. Surgical interventions demand expertise and should be conducted at qualified, high-volume centers. To support clinicians in comprehending the nuances of MU, we conducted a literature review, presenting a summary of our findings. Additionally, we propose an algorithm delineating the escalation of treatments for MU, ranging from medical to endoscopic to surgical therapies. This concise review aims to assist clinicians in both the prevention and treatment of marginal ulceration.

show abstract

Section: Truncal Vagotomymentioning

confidence: 99%

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Baldwin,

Ali,

Altieri

et al. 2024

Metab Target Organ Damage

View full text Add to dashboard Cite

show abstract

“…The results showed that this method obtained an optimal suture task allocation plan, which was beneficial to improve the intelligent degree of robot operation. Brungardt et al ( 28 ) explored the feasibility of right-side robot-assisted transthoracic vagotomy for the treatment of marginal ulcers after gastric bypass surgery for the first time. The patient was a 43-year-old white female who underwent Roux-en-Y gastric bypass surgery at the age of 29.…”

Section: Application Of Ai In Pumentioning

confidence: 99%

Application Status and Prospects of Artificial Intelligence in Peptic Ulcers

et al. 2022

View full text Add to dashboard Cite

Peptic ulcer (PU) is a common and frequently occurring disease. Although PU seriously threatens the lives and health of global residents, the applications of artificial intelligence (AI) have strongly promoted diversification and modernization in the diagnosis and treatment of PU. This minireview elaborates on the research progress of AI in the field of PU, from PU’s pathogenic factor Helicobacter pylori (Hp) infection, diagnosis and differential diagnosis, to its management and complications (bleeding, obstruction, perforation and canceration). Finally, the challenges and prospects of AI application in PU are prospected and expounded. With the in-depth understanding of modern medical technology, AI remains a promising option in the management of PU patients and plays a more indispensable role. How to realize the robustness, versatility and diversity of multifunctional AI systems in PU and conduct multicenter prospective clinical research as soon as possible are the top priorities in the future.

show abstract

Right Robotic-Assisted Transthoracic Truncal Vagotomy for Marginal Ulcer Disease after Gastric Bypass Surgery

Cited by 2 publications

References 4 publications

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Application Status and Prospects of Artificial Intelligence in Peptic Ulcers

Contact Info

Product

Resources

About